Biological effects of human gastrin I and II chemically modified at the tetrapeptide amide

Autor: Richard Magous, Jeanine Laur, J. C. Galleyrand, P. Fulcrand, Jean Martinez, Marc Rodriguez, Jean-Pierre Bali
Rok vydání: 1992
Předmět:
Zdroj: Peptides. 13:519-525
ISSN: 0196-9781
DOI: 10.1016/0196-9781(92)90083-f
Popis: Binding to gastrin receptors and gastric acid secretion experiments were performed with gastrin derivatives modified at the C- terminal tetrapeptide amide from HG-13 sequence. 1. When the ultimate phenylalanine amide was replaced by a phenethylester or a phenetylamide moiety, the resulting compound bound to gastrin receptors ( K d ≈ 10 nM ) and exhibited antagonist activity on gastrin-induced acid secretion in the anesthetized rat. 2. Changing the peptide bond between Trp and Leu residues to a -Ψ(CH 2 -NH)- bond resulted in a compound which also bound to gastrin receptors ( K d ≈ 10 n M ) but presented agonist activity on acid secretion in the rat. In contrast, when the peptide bond between Leu and Asp residues was replaced by a -Ψ(CH 2 -NH)- bond, the resulting compound was devoid of any affinity for gastrin receptor ( K d > 10 −6 M ) and of any biological activity. 3. The HG-13 derivatives were synthesized in sulfated and unsulfated forms: O-sulfation of the HG-13 tyrosine residue did not change its intrinsic in vivo activity but enhanced its affinity for gastrin receptors ( K d ≈ 0.3 n M ). On the contrary, O-sulfation of the various chemically modified HG-13 had no significant effect in either in vitro or in vivo experiments. 4. Finally, no significant difference between binding on parietal (F3) and nonparietal (F1) cells was observed, in agreement with the presence of a gastrin-type receptor in these two cell populations.
Databáze: OpenAIRE